Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

NYSE:REX - US7616241052 - Common Stock

59.9 USD
+2.79 (+4.89%)
Last: 8/22/2025, 4:29:59 PM
59.9 USD
0 (0%)
After Hours: 8/22/2025, 4:29:59 PM
Fundamental Rating

6

Taking everything into account, REX scores 6 out of 10 in our fundamental rating. REX was compared to 209 industry peers in the Oil, Gas & Consumable Fuels industry. REX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, REX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

REX had positive earnings in the past year.
In the past year REX had a positive cash flow from operations.
REX had positive earnings in each of the past 5 years.
Each year in the past 5 years REX had a positive operating cash flow.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

REX's Return On Assets of 8.17% is fine compared to the rest of the industry. REX outperforms 78.95% of its industry peers.
REX has a Return On Equity of 10.56%. This is in the better half of the industry: REX outperforms 61.24% of its industry peers.
REX has a Return On Invested Capital of 7.67%. This is in the better half of the industry: REX outperforms 67.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REX is significantly below the industry average of 23.53%.
The last Return On Invested Capital (7.67%) for REX is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROIC 7.67%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

REX has a Profit Margin (8.86%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of REX has grown nicely.
REX has a worse Operating Margin (10.07%) than 63.16% of its industry peers.
In the last couple of years the Operating Margin of REX has grown nicely.
REX has a worse Gross Margin (14.29%) than 67.94% of its industry peers.
REX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), REX is destroying value.
The number of shares outstanding for REX has been reduced compared to 1 year ago.
Compared to 5 years ago, REX has less shares outstanding
REX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.97 indicates that REX is not in any danger for bankruptcy at the moment.
REX has a Altman-Z score of 6.97. This is amongst the best in the industry. REX outperforms 92.34% of its industry peers.
The Debt to FCF ratio of REX is 0.35, which is an excellent value as it means it would take REX, only 0.35 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of REX (0.35) is better than 92.34% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that REX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, REX belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Altman-Z 6.97
ROIC/WACC0.86
WACC8.97%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

REX has a Current Ratio of 8.45. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.45, REX belongs to the best of the industry, outperforming 95.22% of the companies in the same industry.
REX has a Quick Ratio of 7.80. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.80, REX belongs to the top of the industry, outperforming 95.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.45
Quick Ratio 7.8
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for REX have decreased by -5.19% in the last year.
REX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 54.06% yearly.
REX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.20%.
REX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.99% yearly.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%

3.2 Future

REX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.03% yearly.
REX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.00% yearly.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

REX is valuated rather expensively with a Price/Earnings ratio of 18.21.
Compared to the rest of the industry, the Price/Earnings ratio of REX is on the same level as its industry peers.
When comparing the Price/Earnings ratio of REX to the average of the S&P500 Index (26.76), we can say REX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 19.77, the valuation of REX can be described as rather expensive.
REX's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of REX to the average of the S&P500 Index (34.91), we can say REX is valued slightly cheaper.
Industry RankSector Rank
PE 18.21
Fwd PE 19.77
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of REX indicates a somewhat cheap valuation: REX is cheaper than 68.90% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as REX.
Industry RankSector Rank
P/FCF 102.84
EV/EBITDA 5.44
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of REX may justify a higher PE ratio.
A cheap valuation may be justified as REX's earnings are expected to decrease with -4.03% in the coming years.
PEG (NY)N/A
PEG (5Y)0.34
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for REX!.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (8/22/2025, 4:29:59 PM)

After market: 59.9 0 (0%)

59.9

+2.79 (+4.89%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-25 2025-08-25/bmo
Inst Owners88.43%
Inst Owner Change-3.72%
Ins Owners14.34%
Ins Owner Change10.4%
Market Cap986.55M
Analysts80
Price Target51 (-14.86%)
Short Float %3.23%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)3.38%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)9.23%
Revenue beat(8)4
Avg Revenue beat(8)2.04%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)10
Avg Revenue beat(16)2.8%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.21
Fwd PE 19.77
P/S 1.54
P/FCF 102.84
P/OCF 15.66
P/B 1.84
P/tB 1.84
EV/EBITDA 5.44
EPS(TTM)3.29
EY5.49%
EPS(NY)3.03
Fwd EY5.06%
FCF(TTM)0.58
FCFY0.97%
OCF(TTM)3.82
OCFY6.38%
SpS38.83
BVpS32.57
TBVpS32.57
PEG (NY)N/A
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROCE 9.96%
ROIC 7.67%
ROICexc 15%
ROICexgc 15%
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
FCFM 1.5%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Debt/EBITDA 0.03
Cap/Depr 239.19%
Cap/Sales 8.35%
Interest Coverage 250
Cash Conversion 72.63%
Profit Quality 16.93%
Current Ratio 8.45
Quick Ratio 7.8
Altman-Z 6.97
F-Score5
WACC8.97%
ROIC/WACC0.86
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.53%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.83%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%